[Two new oral disease modifying therapies in relapsing remitting multiple sclerosis]. Lebrun C, de Seze J Rev Neurol (Paris). 2014 Dec; 170(12):721-2. PMID: 25487772. Abstract CommentRecommendBookmarkWatch